top of page
Rick Goulburn MBA
COO, Board Member,
CEO Cynaptec Pharmaceuticals, Inc.,
CEO Alera Pharma, Inc.
MORE ABOUT US
In July of 2024, Lobe Sciences underwent a series of changes in ownership, board, and advisory team.
Short biographies and a brief overview for our company leadership can be found above in both the Our Team tab and on the Corporate Profile page.
Altemia Medical Food
Altemia, Inc. is focused on the commercialization of treatments to address diseases associated with membranopathy.
Membranopathy is a fatty acid disorder caused by an error in metabolism.
Our initial target is a deficiency associated with Sickle Cell Disease (SCD), the rare orphan disease primarily impacting children and young adults.
Cynaptec Pharmaceuticals, Inc.
bottom of page